A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

Impressive listing gains during the post-pandemic bull run have fueled investor confidence, prompting HNIs to allocate funds ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...

Smithfield Foods launched its initial public offering of stock this Tuesday (Jan. 28), selling 26 million shares at $20 each ...

Private equity-backed oil and natural gas producer Infinity Natural Resources on Thursday raised $265 million in its initial ...

Twin Peaks, a sports bar chain, made its debut on the Nasdaq Thursday, marking the first restaurant IPO of 2025.

Companies should not minimize the extent of a material cybersecurity incident by omitting material facts regarding the scope ...

Varindera Constructions and Sambhv Steel Tubes have received SEBI’s final observation to launch their IPOs. Varindera plans ...

When US tech stocks were crushed by the emergence of DeepSeek this week, already-cautious investors found one more reason to ...

Sahanand Medical Technologies (SMT), an Indian cardiovascular device maker backed by private equity firm Samara Capital, is ...

Beta Bionics has announced the pricing of its upsized initial public offering of 12 million shares of common stock at a price to the public of $17 per share.